Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Some individuals taking Semaglutide or Tirzepatide may experience less weight loss than anticipated
Semaglutide (Pronunciation: sem a GLOO tide) is a glucagon-like peptide-1 (GLP-1) receptor agonist
Hormonal life stages such as perimenopause and menopause can affect weight management
Clean Provider Records Minor issues OrderlyMeds works through Beluga Health, a medical-staffing agency with board-certified physicians licensed in all 50 states, so the clinician side checks out
What to track during Phase 1: Nausea frequency and severity (scale of 1 to 10) Appetite changes (especially 24 to 48 hours post-injection) Any GI symptoms (constipation, diarrhea, bloating) Injection site reactions Baseline weight and measurements Do not expect dramatic results here
It supports your muscle mass and helps you meet your daily nutrient needs, even when your overall appetite is lower than it used to be
